AmerisourceBergen snags sterile drug compounder PharMEDium in $2.5B deal

AmerisourceBergen ($ABC) is set to do its second $2.5 billion deal this year, again taking a turn into a new arena. The drug sourcing and distribution giant says it has a deal to buy PharMEDium, a sterile drug compounding specialist with a client list of more than 3,000 acute care hospitals for which it produces specialized products from four centers. In the spring, Valley Forge, PA-based AmerisourceBergen completed a $2.5 billion deal to buy international animal health distribution company MWI Veterinary Supply. Story | More

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.